June 19, 2024

Smart Lipo Recalled for Undeclared, Banned Drugs

Recall SignSmartLipo365 of Dallas is recalling all lots of Smart Lipo capsules because they have been found to contain contain undeclared, banned drugs. Consumers who have purchased these products should not use them as they could cause serious, life-threatening health problems.

All 800, 900 and 950 mg capsules are being recalled after the U. S. Food and Drug Administration (FDA) conducted an analysis and found them to contain sibutramine, desmethylsibutramine, and phenolphthalein which are not declared on the label.

Sibutramine is banned drug.  Before it was removed from the market in 2010 for posing health risks to patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke, it was used as an appetite suppressant.

Phenolphthalein is a banned drug because it has been found to be cancer-causing.  Short-term health risks include potentially serious gastrointestinal disturbances and irregular heartbeat.

In addition, both drugs could interact in life-threatening ways with other medications a consumer may be taking.

The recalled product was sold at Centro Naturista in Richardson, TX, SmartLipo365 in Arlington, TX,  and distributed nationwide through internet sales. At the time of the recall, the company had not received any complaints associated with the product.

Report Your Food Poisoning Case

Error: Contact form not found.


Home About Site Map Contact Us Sponsored by Pritzker Hageman, P.A., a Minneapolis, MN law firm that helps food poisoning victims nationally.